FIXX - Homology Medicines - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FIXX is currently covered by 7 analysts with an average price target of $9.03. This is a potential upside of $8.1 (870.97%) from yesterday's end of day stock price of $0.93.

Homology Medicines's activity chart (see below) currently has 20 price targets and 33 ratings on display. The stock rating distribution of FIXX is 53.33% BUY and 46.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 6.25% with an average time for these price targets to be met of 6.5 days.

Highest price target for FIXX is $3, Lowest price target is $1, average price target is $9.03.

Most recent stock forecast was given by MADHU KUMAR from on 28-Jul-2023. First documented stock forecast 24-Apr-2018.

Currently out of the existing stock ratings of FIXX, 8 are a BUY (53.33%), 7 are a HOLD (46.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1.5

$0.64 (74.42%)

$10

1 years 3 months 27 days ago
(28-Jul-2023)

1/8 (12.5%)

$0.17 (12.78%)

5

Buy

$20

$18.97 (1841.75%)

1 years 6 months 9 days ago
(15-May-2023)

0/1 (0%)

$18.98 (1860.78%)

Hold

$2

$1.14 (132.56%)

$3.21

1 years 6 months 12 days ago
(12-May-2023)

2/4 (50%)

$1.02 (104.08%)

60

Buy

$10

1 years 6 months 12 days ago
(12-May-2023)

0/3 (0%)

$7.96 (390.20%)

Buy

$7

1 years 7 months 18 days ago
(06-Apr-2023)

0/3 (0%)

$4.46 (175.59%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FIXX (Homology Medicines) average time for price targets to be met?

On average it took 6.5 days on average for the stock forecasts to be realized with a an average price target met ratio 6.25

Which analyst has the current highest performing score on FIXX (Homology Medicines) with a proven track record?

RICHARD LAW

Which analyst has the most public recommendations on FIXX (Homology Medicines)?

Richard Law works at GOLDMAN SACHS and has 2 price targets and 2 ratings on FIXX

Which analyst is the currently most bullish on FIXX (Homology Medicines)?

Patrick Trucchio with highest potential upside - $18.97

Which analyst is the currently most reserved on FIXX (Homology Medicines)?

Michelle Gilson with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?